AIGH Capital Management’s Medicenna Therapeutics Corp. Common Shares MDNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-4,339,983
| Closed | -$1.27M | – | 53 |
|
|
2023
Q3 | $1.27M | Hold |
4,339,983
| – | – | 0.6% | 37 |
|
|
2023
Q2 | $2.09M | Sell |
4,339,983
-7,000
| -0.2% | -$3.37K | 0.85% | 30 |
|
|
2023
Q1 | $2.76M | Hold |
4,346,983
| – | – | 1.02% | 26 |
|
|
2022
Q4 | $1.99M | Buy |
4,346,983
+496,829
| +13% | +$228K | 0.66% | 33 |
|
|
2022
Q3 | $3.19M | Buy |
3,850,154
+1,577,454
| +69% | +$1.31M | 0.99% | 21 |
|
|
2022
Q2 | $2.65M | Hold |
2,272,700
| – | – | 0.7% | 21 |
|
|
2022
Q1 | $2.91M | Buy |
2,272,700
+58,400
| +3% | +$74.7K | 0.71% | 22 |
|
|
2021
Q4 | $3.61M | Buy |
2,214,300
+1,299,300
| +142% | +$2.12M | 1.1% | 21 |
|
|
2021
Q3 | $2.54M | Hold |
915,000
| – | – | 0.54% | 34 |
|
|
2021
Q2 | $2.77M | Buy |
915,000
+75,000
| +9% | +$227K | 0.5% | 35 |
|
|
2021
Q1 | $3.43M | Buy |
+840,000
| New | +$3.43M | 0.72% | 28 |
|